FDA grants accelerated approval to dostarlimab for dMMR/MSI-H locally advanced rectal cancer
On 19 October 2026 the FDA granted accelerated approval to Jemperli (dostarlimab) for stage II/III locally advanced rectal cancer.
On 19 October 2026 the FDA granted accelerated approval to Jemperli (dostarlimab) for stage II/III locally advanced rectal cancer.
A systematic review in the Aesthetic Surgery Journal pooled 65 randomised trials with 18,581 participants.
A US study in the Aesthetic Surgery Journal found silicone breast implant flipping in 12.7% of patients.
A systematic review in Plastic and Reconstructive Surgery pooled 12 studies with 29,357 patients.
The Aesthetic Surgery Journal published a multicentre randomised study of Belotero Intense with lidocaine for lip augmentation.
On 8 October 2026 the FDA approved Tecentriq (atezolizumab) with chemotherapy as adjuvant treatment for stage III colon cancer.
On 7 October 2026 WHO released its first global guidelines on caring for children and adolescents with obesity.
An Aesthetic Surgery Journal study compared 1,036 face-and-neck-lift patients with or without tranexamic acid.
An Aesthetic Surgery Journal article examines the ethics of surgeons analysing celebrities' looks on social media.
An analysis of more than 20,000 men with prostate cancer compared surgery with radiation over up to 20 years.
Nothing more to show